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Summary
 Background The EORTC/RTOG late effects classifi cation has been used for many years and cov-
ers nearly all organs and tissues, which may develop late radiation injuries. Dische 
developed a scoring system for radiation toxicity in which each clinical sign or symp-
tom, that is characteristic for disturbance of function in an irradiated organ, is giv-
en scores for severity individually. EORTC and RTOG formed working groups to 
up-date their systems, for the recording of late injury to normal tissues, to be used 
in future clinical trials. The resulting system is called LENT-SOMA (1993).
 Aim In preparation for the introduction of the LENT-SOMA scale into clinical prac-
tice at the Centre of Oncology-Institute in Gliwice, we followed a sizeable cohort 
of patients using two scoring systems for the assessment of delayed radiation tox-
icity at each follow-up examination which took place every 6 months for up to 5 
years after curative radiotherapy for head and neck cancer.
 Materials/Methods The analysed material comprised of 113 patients with oral cavity, pharyngeal or 
supraglottic cancer (T2-4N0-1) irradiated by conventional methods (18 patients), 
continuous accelerated irradiation (CAIR) (52 patients) or concomitant boost 
(CB) (43 patients). Total dose was in the range of 66-74 Gy. Delayed radiation tox-
icity was evaluated by two classifi cation systems, those of Dische and LENT-SOMA, 
in the mucosal membranes, skin, larynx, salivary glands and spinal cord every 6 
months after completion of radiotherapy treatment. The values in every scale were 
normalised (as a proportion of the maximum intensity for all symptoms) which 
permitted statistical comparison of the scales by use of the Wilcoxon test.
 Results Analysis of all materials indicated a difference in the intensity of late radiation 
toxicity as estimated by the Dische and LENT-SOMA scales. The intensity of de-
layed radiation toxicity in the normalised Dische scale, for mucosal membranes 
and for skin, had higher values than observed in the LENT-SOMA system for the 
majority of examined patients. In the case of the larynx and salivary glands, the 
opposite situation was noted. The extent of conformity between normalised scales 
was evaluated in the case of the spinal cord.
 Conclusions The scoring systems of Dische and LENT-SOMA can not be interchangeably used, 
in clinical practice, for the estimation of delayed radiation toxicity in tissues of 
the head and neck region. The sensitivity of the scoring systems is similar only 
for the evaluation of radiation reactions in spinal cord.
 Key words delayed radiation toxicity • head & neck cancer
Received: 2005.01.18
Accepted: 2005.05.13
Published: 2005.09.20
Original Paper
179
Rep Pract Oncol Radiother, 2005; 10(4): 179-192
BACKGROUND
In the treatment of any disease, the therapeu-
tic benefi t has to be balanced against potential 
harmful side-effects. Radiation oncology is a spe-
cial case in that critical changes in normal tissue, 
caused by radiotherapy, appear long after the end 
of treatment and usually develop gradually over a 
period of months and sometimes years. Often they 
can only be revealed by careful long-term follow 
up of patients, and the use of standardised exam-
ination protocols. As cancer treatment becomes 
more effective, and as more patients survive for 
longer periods, the importantance of long-term 
morbidity will increase even further.
Innovations in radiation oncology are designed 
to improve the long-term control of malignant 
disease, but may also lead to increasing sever-
ity and frequency of untoward acute effects. 
Examples of such innovations include deliver-
ing higher doses to the tumour volume, new frac-
tionation schedules such as hyperfractionation 
and/or accelerated fractionation and strategies 
for the combination of other therapeutic modali-
ties, such as surgery or chemotherapy with radia-
tion. The optimal therapeutic ratio will ultimate-
ly depend equally on the frequency of complete 
tumour clearance and on the incidence rate of 
unacceptable long term radiation injury to sur-
rounding, vital, normal tissues and organs.
Methods are required for the quantitative descrip-
tion of the severity of signs and symptoms of pro-
gressive late radiation damage. Such methods per-
mit a rational comparison and balance between 
tumour effects and the late side effects of alterna-
tive treatment protocols. The EORTC/RTOG late 
effects classifi cation has been used for many years 
and covers nearly all organs and tissues, which 
may develop late radiation injuries. It is well rec-
ognised, however, that there are diffi culties when 
comparing one study with another, since there 
appears to be no common language with regard 
to late morbidity effects. Dische [1] analysed a 
large number of consecutive papers in a leading 
journal of radiation oncology and described con-
siderable variability in the reporting of compli-
cations. He noted that the EORTC/RTOG scale 
was not consistently applied by different investi-
gators. Therefore, Dische [1] developed a scor-
ing system for radiation toxicity in which each 
clinical sign or symptom, that is characteristic for 
disturbance of function in an irradiated organ, 
is given scores for severity individually. The to-
tal sum of all the severity values for listed symp-
toms is the overall measure of late radiation tox-
icity according to this scale.
The two large organisations that initiated and co-
ordinated the multicentre clinical trials in Europe 
and in North America, the EORTC [2] and the 
RTOG [3], formed working groups to up-date 
their systems, for the recording of late injury to 
normal tissues, to be used in future clinical tri-
als. The resulting system is called LENT-SOMA 
and has been in use since 1993. The response of 
each organ or tissue included in the irradiated 
volume is assessed by four separate criteria: sub-
jective symptoms, objective signs, management 
of signs and symptoms and the fi ndings of spe-
cial analytical investigations. In this scoring sys-
tem, all four aspects play a role in defi ning the 
overall level of late radiation toxicity.
In both scoring systems, the grades vary with time 
after radiotherapy and need to be re-recorded 
each time a patient is seen in follow-up clinics.
AIM
Although numerous publications have been de-
voted to the subject of scoring delayed normal 
tissue damage after radiotherapy, no systematic 
study has been undertaken in which the same co-
hort of patients is compared by both of the recom-
mended scoring systems. Therefore, in prepara-
tion for the introduction of the LENT-SOMA scale 
into clinical practice at the Centre of Oncology-
MSC Institute in Gliwice, we followed a sizeable 
cohort of patients for a period of up to 5 years 
using both scoring systems at each follow-up ex-
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amination. These examinations took place eve-
ry 6 months for each patient.
MATERIALS AND METHODS
We systematically recorded the development of 
delayed normal tissue injury in 113 patients with 
advanced cancer of the oral cavity, pharyngeal 
cancer or supraglottic cancer (AJCC) T2-4N0-1M0, 
who were irradiated between the years 1994 and 
2000 in the Centre of Oncology in Gliwice. All 
patients were irradiated radically using an exter-
nal megavoltage beam of Co60 or X 6 MV and a 
two parallel opposing fi elds technique. All were 
in good condition (ZUBROD <2) and aged 70 
years or less. The dose per fraction was 1.8 or 2.0 
Gy. 18 patients received 5 weekly fractions of 2 
Gy per fraction (“conventional”), 52 patients re-
ceived 7 weekly fractions of 1.8 Gy per fraction, 
by continuous accelerated irradiation (CAIR), 
and 43 patients were irradiated with a concomi-
tant boost schedule in which the reduced boost 
fi eld was given a second dose, of 1.8 Gy, 6 hours 
after the dose to the large fi eld each week (CB). 
The total dose was in the range of 66–74 Gy. The 
parameters of the 3 treatment protocols are de-
scribed in Table 1.
Delayed radiation toxicity was evaluated by two 
classifi cation systems, Dische and LENT-SOMA, 
for selected critical tissues, as follows: pharyngeal 
and oral cavity mucosal membranes (Table 2), 
skin (Table 3), larynx (Table 4), salivary glands 
(Table 5) and spinal cord (Table 6). Estimations 
were made every 6 months after completion of ra-
diotherapy. Colour photographs of the skin and 
mucosal membranes were made and direct laryn-
goscopy was performed for assessment of chang-
es in appearance. In order to monitor delayed 
radiation toxicity in a group of patients with neu-
rological disturbances, MRI scans of the cervical 
spinal cord were employed. Salivary fl ow analysis 
was not performed in the investigation of the sal-
ivary glands.
The two scoring systems cover a different range 
of values for each organ. A completely asympto-
matic patient would score 0 in both scoring sys-
tems for all organs, whereas the maximum val-
ues of each scale are different for each organ 
and also between organs. In order to compare 
the clinical usefulness of the two systems, some 
normalisation was required. Each recorded val-
ue was presented as a proportion of the theoret-
ical maximum values, i.e. the sum of maximum 
severity scores of all S, O and M variables in the 
LENT-SOMA scale and analogous criteria in the 
Dische scale. The Wilcoxon test was used for sta-
tistical comparison of the two scales.
RESULTS
Analysis has indicated that, for most organs, sys-
tems do not differ signifi cantly in the quantifi ca-
tion of delayed radiation toxicity.
Intensity in the mucosal membranes progressed 
to its highest level over 30 months in both scales 
(Figure 1). It was associated with higher values 
for telangiectasia and dysphagia in the Dische 
system than in the LENT-SOMA scale (Table 7). 
Superfi cial ulceration of the mucosal membrane 
was observed in one patient 6 months after radi-
otherapy, but healed after this period. A second 
patient (CB schedule) with ulceration which was 
developing from 18 months after completing ra-
diotherapy to form osteoradionecrosis of mandi-
ble – was qualifi ed for salvage surgery.
For skin, the intensity of delayed radiation tox-
icity in the normalised Dische scale had signif-
icantly higher values than in the LENT-SOMA 
scale for the majority of examined patients. The 
intensity of reactions increased until 24 months 
after treatment and then slowly stabilised in both 
scales (Figure 2). Atrophy and fi brosis had high-
er values in the Dische scale. Telangiectasia and 
alopecia were comparable however (Table 8).
In the case of the larynx, the intensity of delayed 
radiation reactions always had higher values in the 
LENT-SOMA scale than in that of Dische (Figure 
3). No ulceration, chondritis or necrosis was ob-
served according to Dische system. Hoarseness 
and oedema rose to moderately high values up 
to 24 months after irradiation but subsequently 
decreased. Telangiectasia remained stable during 
the whole period of observation and dyspnoea 
on exertion, observed in three patients, was no 
longer evident after 30 months (Table 9).
The intensity of delayed radiation effects on the 
salivary glands increased over the course of the 
fi rst 30 months after the conclusion of radiother-
apy, according to the LENT-SOMA system, and 
for 12 months according to the Dische scale. 
After this period, the effects diminished until 60 
months after completion of therapy (Figure 4). 
Dryness of mouth and consistency of saliva after 
irradiation had higher values in the Dische scale. 
Generally, the intensity of reactions in the sali-
vary glands was rated higher in the LENT-SOMA 
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CAIR, CB Conventional radiotherapy
68.4–72.0 total dose (Gy) 66.0–74.0
1.8 fraction dose (Gy) 2.0
7×/week fractionation method 5×/week
38–40 total treatment time (days) 45–55
Table 1. Physical parameters of irradiation.
0 1 2 3 4
dysphagia no
some discomfort 
in swallowing, no 
disturbance of diet
diﬃ  culty
in swallowing,
soft diet required
considerable diﬃ  culty
in swallowing,
ﬂ uids only
severe
diﬃ  culty
in swallowing ﬂ uids
atrophy nil yes
telangiectasia nil minimal distinct severe
ulceration
   – depth
   – distribution
nil
nil
superﬁ cial
patchy
deep
orocutaneous ﬁ stula no yes
Table 2A. Delayed radiation reactions of the mucosa according to Dische’s scale.
Stage 1 2 3 4
subjective
pain occasional & minimal intermittent & tolerable persistent & intense refractory & excruciating
dysphagia diﬃ  culty eating solid food diﬃ  culty eating soft food can take liquids only totally unable to swallow
taste alteration occasional, slight intermittent persistent
objective
mucosal integrity patchy atrophy or TELANGIECTASIA
diﬀ use atrophy or 
TELANGIECTASIA, superﬁ cial 
ulcer
deep ulcer with no bone or 
cartilage exposure
deep ulcer with bone or 
cartilage exposure
management
pain occasional, non narcotic regular, non-narcotic regular, narcotic surgical intervention
ulcer cleanse antibiotics or oxidants surgical intervention
dysphagia lubricants, diet modiﬁ cation non narcotic narcotic PEG tube and/or surgical intervention
taste alteration minor diet changes(non-acidic)
minor diet changes
(semi-soft)
major diet changes
(soft)
major diet changes
(liquid)
analytic
colour photo assessment of changes in appearance
cytology, biopsy rule out persistent tumor
smear, culture,
anti-fungal trial rule out candidiasis
Table 2B. Delayed radiation reactions of the mucosa according to the LENT-SOMA scale.
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0 1 2 3 4
pigmentation nil slight increase moderate increase very marked decrease
telangiectasia nil slight moderate marked
atrophy nil mild moderate severe
hair loss nil slight moderate complete
sweating no change deﬁ nite reduction absent
subcutaneous tissues
   – induration ﬁ brosis
   – subcutaneous fat loss
nil
nil
slight
slight
moderate
moderate
severe
severe
Table 3A. Delayed radiation reactions of the skin & subcutaneous tissues according to Dische’s scale.
Stage 1 2 3 4
subjective
scaliness/roughness present/asymptomatic symptomatic require constant attention
sensation hypersensitivity, pruritus intermittent pain persistent pain debilitating dysfunction
objective
oedema present/asymptomatic symptomatic secondary dysfunction total dysfunction
alopecia (scalp) thinning patchy, permanent complete, permanent
pigmentation change transitory, slight permanent, marked
ulcer / necrosis epidermal only dermal subcutaneous bone exposed
TELANGIECTASIA minor moderate <50% gross ≥50%
ﬁ brosis/scar present / asymptomatic symptomatic secondary dysfunction total dysfunction
atrophy/contraction present / asymptomatic symptomatic/<10% secondary dysfunction/10–30% total dysfunction/>30%
management
dryness medical intervention
sensation intermittent medical intervention
continuous medical 
intervention
ulcer Medical intervention Surgical intervention/amputation
oedema Medical intervention Surgical intervention/amputation
ﬁ brosis / scar Medical intervention Surgical intervention/amputation
analytic
colour photographs assessment of changes in appearance
Table 3B. Delayed radiation reactions of the skin & subcutaneous tissues according to the LENT-SOMA scale.
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0 1 2
ulceration nil superﬁ cial deep
chondritis no yes
necrosis nil yes
Table 4A. Delayed radiation reactions of the larynx according to Dische’s scale.
Stage 1 2 3 4
subjective
pain occasional & minimal intermittent & tolerable persistent & intense refractory & excruciating
voice/hoarseness occasional hoarseness on prolonged use
intermittent hoarseness, 
voice unreliable, varies in 
day-to-day communication
persistent hoarseness, 
incapable of normal 
communication
complete loss of voice
breathing occasional diﬃ  culty intermittent diﬃ  culty laboured breathing stridor
objective
edema arytenoids only arytenoids and aryepiglottic folds
diﬀ use edema of the 
supraglottis, airway 
adequate
diﬀ use with signiﬁ cant 
narrowing of airway, <1/2 
normal
mucosal integrity patchy atrophy, TELANGIECTASIA
complete atrophy, extensive 
TELANGIECTASIA ulcer, cartilage not exposed necrosis, cartilage exposed
respiration dyspnoea on exertion labored at rest stridor et rest
management
pain occasional non-narcotic regular non-narcotic regular narcotic surgical intervention
hoarseness rest voice, or whisper only no talking or whispering laryngectomy
respiration humidiﬁ er, steroids temporary tracheostomy permanent tracheostomy
analytic
indirect laryngoscopy assessment of oedema, mucosal integrity, vocal cord motion, ulcer, necrosis
direct laryngoscopy assessment of oedema, mucosal integrity, vocal cord motion, ulcer, necrosis
CT assessment of oedema, necrosis, asymmetry
MRI assessment of oedema, necrosis, asymmetry
Table 4B. Delayed radiation reactions of the larynx according to the LENT-SOMA scale.
0 1 2 3
dryness of mouth nil mild moderate severe
saliva – consistency normal watery thick sticky
loss of taste nil minimal partial marked
induration no minimal deﬁ nite marked
Table 5A. Delayed radiation reactions of the salivary glands according to Dische’s scale.
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Stage 1 2 3 4
subjective
xerostomia occasional dryness partial but persistent dryness complete dryness, non-debilitating
complete dryness, 
debilitating
objective
saliva normal moisture scant saliva absence of moisture, sticky, viscous saliva
absence of moisture, coated 
mucosa
management
xerostomia
occasional saliva substitute,
sugarless candy or gum,
sialogogues
frequent saliva substitute or 
water
sugarless candy or gum
sialogogues
needs saliva substitute or 
water in order to eat
sugarless candy or gum
sialogogues
analytic
salivary
ﬂ ow/quantity/stimulation 76–95% of pre-treatment 51–75% of pre-treatment 26– 50% of pre-treatment 0–25% of pre-treatment
Table 5B. Delayed radiation reactions of the salivary glands according to the LENT-SOMA scale.
0 1 2 3 4
lhermitte’s syndrome nil yes
paresthesia nil slight moderate marked
paraparesis nil mild moderate severe complete
sensory loss no mild moderate marked complete
bladder function no change impaired lost
radiology spinal cord no yes
anal sphincter function no change impaired
limb movement limitation
Table 6A. Delayed radiation reaction of the spinal cord according to Dische’s scale.
Mucosal mebrane
0.30
0.25
0.20
0.15
0.10
0.05
0.00
No
rm
ali
sa
te
d s
ca
le
6           12         18        24         30         36         42         48         54        60
Months after radiotherapy
SOMA-LENT
Dische
mean ± standard error
* p<0.05
*
*
*
Figure 1. Mean values for delayed radiation toxicity according 
to two scoring systems, LENT-SOMA and Dische, following post-
radiotherapy examinations.
Skin
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Figure 2. Mean values for delayed radiation toxicity in the skin 
according to two scoring systems, LENT-SOMA and Dische, during 
follow-up examinations after radiotherapy.
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Stage 1 2 3 4
subjective
paresthesia (tingling 
sensation, shooting pain, 
lhermitte’s syndrome)
occasional & minimal intermittent & tolerable persistent & intense refractory & excruciating
sensory (numbness) minimal change mild unilateral sensory loss
partial unilateral sensory 
loss; needs assistance for 
self care
total loss of sensation, 
danger of self-injury
motor (weakness) minor loss of strength weakness interfering with normal activities
persistent weakness 
preventing basic activities paralysis
sphincter control occasional loss intermittent loss incomplete control complete incontinence
objective
neurological evaluation
barely detectable decrease in 
sensation or motor weakness 
on one side
easily detectable decrease in 
sensation or motor weakness 
on one side, disturbs but 
does not prevent function
full brown-sequard 
syndrome, loss of sphincter 
function, prevents function
complete transection, 
disabling, requiring 
continuous care
management
pain occasional non narcotic medication
persistent non-narcotic 
medication, intermittent low 
dose steroids
intermittent high dose 
steroids persistent high dose steroids
neurological function needs minor adaptation to continue working regular physiotherapy
intensive physiotherapy plus 
regular supervision intensive nursing
incontinence occasional use of incontinence pads
intermittent use of 
incontinence pads
regular use of incontinence 
pads or self-catheterisation
permanent use of pads or 
catheterisation
analytic
MRI edema localized demyelination extensive demyelination necrosis
CT assessment of swelling, edema, atrophy
MRS assessment of chemical spectra
PET assessment of metabolic activity
serum assessment of myelin basic protein levels
CSF assessment of total protein and myelin basic protein
Table 6B. Delayed radiation reactions of the spinal cord according to the LENT-SOMA scale.
Larynx
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Figure 3. Mean values for delayed radiation toxicity in the larynx 
according to two scoring systems, LENT-SOMA and Dische, during 
follow-up examinations after radiotherapy.
Salivary glands
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Figure 4. Mean values for delayed radiation toxicity in the salivary 
glands according to two scoring systems, LENT-SOMA and Dische, 
during follow-up examinations after radiotherapy.
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system, because less symptoms are taken into ac-
count than in the Dische system. The manage-
ment of dryness is an important issue after ir-
radiation and, in our material, the high values 
stabilised between 6 and 60 months after com-
pletion of therapy. (Table 10).
Conformity of the normalised scales was eval-
uated for the spinal cord. Signifi cant progres-
sion of (mild, functional) delayed toxicity was 
observed during the second year of treatment 
(Figure 5). Higher levels were observed in the 
Dische system after 24 months, owing to the in-
fl uence of normalised values for Lhermitte’s syn-
drome (Table 11).
DISCUSION
We report observations on the development of 
late normal tissue damage in several critical or-
gans over a period of up to 5 years. These obser-
vations were made in a fi xed cohort of patients, 
at 6 month intervals, by a single observer. The or-
gans examined are often inlcluded in the plan-
ning of radiotherapy target volumes in cases of 
head and neck cancers such as those of the oral 
and pharyngeal mucosal membranes, skin, larynx, 
salivary glands and spinal cord. The clinical ob-
servations at each examination were document-
ed in parallel using the LENT-SOMA and Dische 
scoring systems. Analysis permitted defi nition of 
intensity and study of the dynamics of delayed ra-
diation reactions during follow-up.
The degree of radiation damage to the mucosal 
membranes varies widely according to the size 
of the dose, the quality of radiation and dos-
ing schedules. Atrophy, ulceration and fi brosis 
are induced to varying degrees in the oropha-
ryngeal mucosal membrane. During a one to 
Mucosal membrane
months after radiotherapy
6 12 18 24 30 36 42 48 54 60
LENT-SOMA
subjective
pain 0.11 0.03 0.03 0.06 0.04 0.03 0.03 0.05 0.03 0.03
dysphagia 0.09 0.13 0.12 0.12 0.12 0.07 0.08 0.07 0.03 0.03
taste alteration 0.26 0.27 0.17 0.24 0.13 0.07 0.09 0.10 0.02 0
objective
mucosal integrity 0.06 0.10 0.09 0.13 0.12 0.12 0.13 0.09 0.11 0.12
weight 0.13 0.10 0.09 0.14 0.12 0.08 0.08 0.10 0.04 0.01
management
pain 0.02 0.02 0 0 0 0.01 0.01 0.02 0 0
ulcer 0.01 0 0.02 0.02 0 0 0 0 0 0
dysphagia 0.09 0.06 0.07 0.09 0.09 0.05 0.05 0.03 0.01 0.03
taste alteration 0.07 0.06 0.06 0.09 0.08 0.04 0.06 0.05 0.02 0.01
dische
dysphagia 0.10 0.14 0.13 0.16 0.13 0.10 0.10 0.11 0.04 0.05
atrophia 0.08 0.16 0.07 0.11 0.10 0.11 0.12 0.09 0.11 0.05
telangiectasia 0.09 0.18 0.14 0.19 0.22 0.23 0.19 0.14 0.18 0.21
ulceration – depth 0.03 0 0.03 0.03 0 0 0 0 0 0
ulceration – distribution 0.01 0 0.03 0.03 0 0 0 0 0 0
orocutaneous ﬁ stula 0 0 0 0 0 0 0 0 0 0
Table 7. Mean normalised values for examined signs and symptoms in the mucosal membrane.
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fi ve year period, there is a generally continuous 
chronic stage, and even a slow progression to 
the degree of fi broatrophy with telangiectasia 
in some areas [4]. In the analysed material, we 
observed a stabilisation in radiation reactions 
of the mucosal membranes from 36 months, ac-
cording to the LENT-SOMA system, and from 
30 months by the Dische scale (Figure 1). The 
intensity of delayed effects in the mucosal mem-
branes was decreasing and, we noticed, lower 
grades were being recorded for dysphagia and 
taste alteration.
Generally, the same radiation-induced respons-
es and lesions, which have been described for 
the mucosal membrane, are also induced to var-
ying degrees in the skin. After the fi rst year, the 
skin in the treatment fi eld is depigmented and 
atrophied, with some retraction. Telangiectasia 
may be diffusely distributed throughout the en-
tire fi eld. Chronic changes may include epilation 
and suppression of glandular activity. Ulceration 
occurs rarely and often is associated with re-irradi-
ation. The deep fi brosis sometimes noticed after 
radiotherapy now occurs seldomly and is more a 
Skin
months after radiotherapy
6 12 18 24 30 36 42 48 54 60
LENT–SOMA
subjective
scaliness/roughness 0.05 0.04 0.04 0.09 0.03 0.06 0.07 0.03 0.02 0.04
sensation 0.03 0 0.02 0.02 0.01 0 0 0.01 0.01 0.01
objective
oedema 0.07 0.08 0.03 0.04 0.02 0.03 0.01 0.02 0.01 0.01
alopecia (scalp) 0.38 0.51 0.46 0.48 0.43 0.42 0.47 0.45 0.51 0.51
pigmentation change 0.22 0.25 0.32 0.41 0.40 0.41 0.38 0.39 0.39 0.39
ulcer/necrosis 0.01 0 0.03 0.03 0 0 0 0 0 0
telangiectasia 0.08 0.12 0.18 0.25 0.24 0.25 0.24 0.22 0.21 0.26
ﬁ brosis/scar 0.06 0.04 0.08 0.10 0.09 0.09 0.11 0.12 0.12 0.13
atrophy/contraction 0.03 0.04 0.05 0.11 0.08 0.10 0.09 0.06 0.09 0.12
management
dryness 0.02 0 0.03 0.05 0.09 0.06 0.07 0.05 0.05 0.07
sensation 0 0 0 0 0 0 0 0 0 0
oedema 0 0 0 0 0.01 0.01 0 0 0 0
ﬁ brosis/scar 0.02 0 0 0 0 0 0 0 0 0
ulcer 0 0 0 0 0 0 0 0.01 0 0
dische
pigmentation 0.10 0.13 0.16 0.20 0.19 0.20 0.18 0.20 0.20 0.24
telangiectasia 0.09 0.14 0.16 0.21 0.24 0.26 0.25 0.24 0.24 0.26
atrophy 0.05 0.08 0.09 0.14 0.13 0.13 0.12 0.12 0.12 0.16
hair loss 0.41 0.53 0.52 0.50 0.46 0.42 0.46 0.44 0.49 0.44
sweating 0.06 0.02 0.03 0.05 0.05 0.04 0.05 0.02 0.04 0.03
subcutaneous tissues – induration ﬁ brosis 0.09 0.04 0.11 0.14 0.11 0.14 0.16 0.15 0.15 0.14
subcutaneous tissues –subcutaneous fat loss 0.04 0.04 0.07 0.11 0.09 0.12 0.13 0.11 0.14 0.16
Table 8. Mean normalised values for signs and symptoms in the skin.
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cosmetic defect than a functional one [5]. In our 
material, the average values for delayed reactions 
of the skin showed increases up to 24 months after 
treatment according to both scales, but stabilised 
during the period 30–60 months after treatment 
(Figure 2). Telangiectasia was the most frequent-
ly observed symptom, along with minimal fi brosis 
and epilation of the chin region in males.
Laryngeal chondronecrosis occurs rarely (<1%) at 
conventional daily fractions of 2.0 Gy to total dos-
es of 70 Gy [6]. If larger daily fractions are used, 
the risk increases. Chondronecrosis may result as 
a complication when irradiation is employed in 
the treatment of extensive laryngeal carcinomas. 
The irradiation of tumours, which invade and 
destroy the epiglottis, thyroid or arytenoid car-
Salivary glands
months after radiotherapy
6 12 18 24 30 36 42 48 54 60
LENT-SOMA
subjective
xerostomia 0.43 0.47 0.40 0.39 0.39 0.38 0.35 0.34 0.29 0.33
objective
saliva 0.53 0.63 0.54 0.59 0.58 0.55 0.53 0.53 0.49 0.49
management
xerostomia 0.33 0.19 0.23 0.28 0.40 0.34 0.33 0.31 0.24 0.30
dische
dryness of mouth 0.61 0.64 0.52 0.54 0.53 0.49 0.50 0.47 0.35 0.37
saliva – consistency 0.63 0.77 0.62 0.68 0.65 0.58 0.56 0.58 0.57 0.61
loss of taste 0.25 0.28 0.17 0.21 0.10 0.07 0.08 0.11 0.05 0.02
induration 0.03 0.03 0.07 0.08 0.04 0.04 0.05 0.04 0.04 0.04
Table 10. Mean normalised values for signs and symptoms in the salivary glands.
Larynx
months after radiotherapy
6 12 18 24 30 36 42 48 54 60
LENT-SOMA
subjective
pain 0.09 0.04 0.04 0.05 0.03 0.03 0.02 0.04 0.03 0.04
voice/hoarseness 0.23 0.21 0.22 0.24 0.17 0.18 0.17 0.15 0.16 0.13
breathing 0.06 0.04 0.01 0.01 0.02 0.02 0.03 0.04 0.04 0.04
objective
oedema 0.18 0.12 0.11 0.13 0.10 0.06 0.10 0.10 0.09 0.08
mucosal integrity 0.05 0.07 0.09 0.11 0.11 0.11 0.09 0.10 0.11 0.10
respiration 0.05 0.02 0 0 0.02 0 0 0.01 0 0
management
pain 0.02 0.01 0.01 0.01 0 0.01 0.01 0.01 0 0
hoarseness 0.03 0.02 0.01 0.03 0.02 0.02 0.03 0.04 0.05 0.08
respiration 0.02 0 0 0.04 0.04 0.06 0.07 0.06 0.05 0.08
Table 9. Mean normalised values for signs and symptoms in the larynx.
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tilages is a calculated risk. Another radiation re-
lated complication of laryngeal treatment, which 
is more common than chondronecrosis, is laryn-
geal oedema. The TD 5/5 and TD 50/5 of 50 Gy 
and 70 Gy respectively are based on the literature 
[7]. Fu [8] noted a 13.7% incidence of laryngeal 
oedema at doses lower than 70 Gy, rising rapidly 
to 46.2% at doses of 70 Gy and above.
In our material, the intensity of delayed radiation 
reactions in the larynx always scored higher on the 
LENT-SOMA scale than on that of Dische (Figure 
3). Oedema of the arytenoido-epiglottidean plica 
and arytenoid regions was noted in our patients as 
stabilising at a very low level 24 months after irradi-
ation. Ulceration, chondrolysis and necrosis, basic 
symptoms in the Dische scale, did not occur and 
thus a value of “0” was recorded for every patient 
Spinal cord
months after radiotherapy
6 12 18 24 30 36 42 48 54 60
LENT-SOMA
subjective
paresthesia (tingling sensation, shooting 
pain, lhermitte’s syndrome) 0.06 0.02 0.03 0.09 0.07 0.07 0.04 0.05 0.05 0.05
sensory (numbness) 0.04 0.01 0.03 0.08 0.07 0.06 0.04 0.06 0.05 0.05
motor (weakness) 0.01 0.01 0.02 0.03 0.03 0.04 0.03 0.02 0.01 0
sphincter control 0.01 0 0 0.02 0.01 0 0 0 0 0
objective
neurologic evaluation 0.03 0.01 0.03 0.07 0.06 0.07 0.04 0.04 0.04 0.04
management
pain 0 0 0.01 0 0.01 0 0 0.01 0 0
neurologic function 0 0 0 0.01 0 0 0 0 0 0
incontinence 0 0 0 0 0 0 0 0 0 0
dische
lhermitte’s syndrome 0.15 0.03 0.03 0.19 0.18 0.15 0.12 0.11 0.14 0.16
paresthesia 0.08 0.02 0.04 0.11 0.11 0.10 0.08 0.10 0.08 0.09
paraparesis 0.01 0 0 0.01 0.00 0.01 0.00 0.01 0 0
sensory loss 0.02 0 0.02 0.04 0.03 0.03 0.01 0.02 0.01 0.01
bladder function 0 0 0 0.01 0 0 0 0 0 0
radiology spinal cord 0 0 0 0 0 0 0 0 0 0
anal sphincter function 0 0 0 0 0 0 0 0 0 0
limb movement limitation 0 0 0 0.01 0 0.01 0 0.01 0 0
Table 11. Mean normalised values for signs and symptoms in the spinal cord.
Spinal cord
0.30
0.25
0.20
0.15
0.10
0.05
0.00
No
rm
ali
sa
te
d s
ca
le
6           12         18        24         30         36         42         48         54        60
Months after radiotherapy
SOMA-LENT
Dische
mean ± standard error
* p<0.05
*
Figure 5. Mean values for delayed radiation toxicity in the spinal 
cord according to two scoring systems, LENT-SOMA and Dische, 
during follow-up examinations after radiotherapy.
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in the analysed cohort. Clinical advancement of 
laryngeal cancer in two patients required trache-
otomy before treatment, and cicatrization within 
the larynx did not allow for de-canulation. No pa-
tients required tracheotomy after irradiation.
Dryness of the mouth, associated with decreasingly 
moist saliva, is an important symptom after irradia-
tion of the head and neck region. Generally, if some 
portion of the major salivary gland has been spared, 
dryness of the mouth subsides after 6 to 12 months. 
If xerostomia persists beyond one year, the chance of 
a signifi cant return of function and fl ow is less likely. 
A major secondary complication is the development 
of radiation induced caries and mandibular necrosis 
[5]. Tolerance doses (TD 50/5) differ in range, 40–
65 Gy according to Mossman and al. [9] and 70 Gy 
according to Rubin and Cassaret [5]. In our materi-
al, a signifi cant portion of the salivary glands were in-
cluded into the target volumes and total doses were in 
the range of 66–74 Gy. The intensity of radiation tox-
icity for the salivary glands increased up to 30 months 
after completion of therapy according to the LENT-
SOMA scale, but later decreased. The intensity of 
delayed effects as ascertained by the Dische system 
showed increases to 24 months followed by decreases 
to 60 months (Figure 4). Dryness of the mouth was a 
persistent symptom in the majority of patients.
Spinal cord radiation toxicity can be characterised 
by different symptoms. Paresthesia (shooting pain) 
and Lhermitte’s syndrome, numbness, motor weak-
ness and loss of sphincter control, were assessed in 
a neurological examination to identify a cumula-
tive cord level. Clinically, Lhermitte’s syndrome oc-
curs 2–4 months after irradiation and then persists 
or returns at 6 months. Paresis, numbness, altered 
sphincter control appearing at 6 to 12 months with 
progression comprise the classic onset of radiation-
induced spinal cord transaction [10]. The length 
of the latent period decreases with increasing dose 
and appears to be shorter among children who de-
velop radiation myelopathy than among adults [11]. 
The latent period is also decreased after more than 
one treatment course to the same segment of spi-
nal cord [12]. The most widely observed dose limit 
for the spinal cord is 45 Gy in 22–25 fractions with 
an incidence of myelopathy of less than 0.2% [13]. 
The TD5/5 level is probably between 57 and 61 Gy 
and the TD50 is between 68 and 73 Gy. No volume 
effect has been shown. Shortening the interval from 
23 hours to between 6 and 8 hours reduces spinal 
cord tolerance by 10% to 15% [14]. While neuro-
logical examination has an important role in clin-
ical detection, the most important area is radiolog-
ical imaging. MRI scans may show cord swelling or 
atrophy, decreased intensity on T1-weighted imag-
es, or increased intensity on T2-weighted images. 
Such changes are indicative of oedema, necrosis 
or demyelination patterns [15].
In the analysed material, the peak intensity for 
spinal cord radiation toxicity was observed 24 
months after radiotherapy with good conformi-
ty between scoring systems. All patients were ex-
amined regularly by a single neurologist every 6 
months after irradiation. MRI scans of the spinal 
cord were performed in 20 patients (17.5%) who 
presented with neurological complications during 
clinical examinations at follow-up. There were no 
radiological abnormalities within the spinal cord 
and any neurological problems were found to be 
associated with cervical spondylosis.
In summary, the progress of late radiation reactions 
in the mucosal membranes, skin, larynx, salivary 
glands and spinal cord, may be evaluated by the scor-
ing systems of Dische and LENT-SOMA. The extent 
of conformity of the normalised scales was evaluat-
ed in the case of the spinal cord because the com-
ponent symptoms of delayed radiation reactions, 
and measures of their intensity, are similar in every 
scoring system. Management and analytical methods 
play an important role in the assessment of delayed 
radiation reaction intensity for all of the examined 
tissues and it is therefore necessary to include them, 
as proposed in the LENT-SOMA system.
CONCLUSIONS
1. The scoring systems, Dische and LENT-SOMA, 
can not be used interchangeably in clinical prac-
tice, for the estimation of delayed radiation tox-
icity in tissues of the head and neck region.
2. The LENT-SOMA scoring system is more pre-
cise, in our opinion, than the Dische scale, but 
will require further exploration.
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